Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Staib

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Canadian Journal of Gastroenterology & Hepatology|May 7, 2019
Loss of <i>LLGL1</i> Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal MetastasesAlexander Desuki, Frank Staib, Ines Gockel, et al.
International Journal of Cancer|August 28, 2009
Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathwaySarah J Seitz, Elisa Schulze Schleithoff, Andreas Koch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 11, 2013
CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell linesFrank Staib, Markus Krupp, Thorsten Maass, et al.
Molecular Cancer|August 16, 2012
Genetic signatures shared in embryonic liver development and liver cancer define prognostically relevant subgroups in HCCDiana Becker, Ioannis Sfakianakis, Markus Krupp, et al.
Cell Cycle (Georgetown, Tex.)|June 29, 2010
ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondriaAndré Schuster, Tobias Schilling, Vincenzo De Laurenzi, et al.
Cancer Research|November 17, 2005
The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stressFrank Staib, Ana I Robles, Lyuba Varticovski, et al.
Bioinformatics (Oxford, England)|September 20, 2014
Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesisTimo Itzel, Peter Scholz, Thorsten Maass, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
Journal of Cancer Research and Clinical Oncology|February 16, 2017
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin careCarl Christoph Schimanski, Frank Staib, Thomas Göhler, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Canadian Journal of Gastroenterology & Hepatology|May 7, 2019
Loss of <i>LLGL1</i> Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal MetastasesAlexander Desuki, Frank Staib, Ines Gockel, et al.
International Journal of Cancer|August 28, 2009
Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathwaySarah J Seitz, Elisa Schulze Schleithoff, Andreas Koch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 11, 2013
CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell linesFrank Staib, Markus Krupp, Thorsten Maass, et al.
Molecular Cancer|August 16, 2012
Genetic signatures shared in embryonic liver development and liver cancer define prognostically relevant subgroups in HCCDiana Becker, Ioannis Sfakianakis, Markus Krupp, et al.
Cell Cycle (Georgetown, Tex.)|June 29, 2010
ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondriaAndré Schuster, Tobias Schilling, Vincenzo De Laurenzi, et al.
Cancer Research|November 17, 2005
The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stressFrank Staib, Ana I Robles, Lyuba Varticovski, et al.
Bioinformatics (Oxford, England)|September 20, 2014
Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesisTimo Itzel, Peter Scholz, Thorsten Maass, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
Journal of Cancer Research and Clinical Oncology|February 16, 2017
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin careCarl Christoph Schimanski, Frank Staib, Thomas Göhler, et al.
Pageof 2